Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony G Marson

Showing results (131-140 of 247) with videos related to

Pageof 25
Sort By:
The Lancet. Neurology|March 2, 2012
Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trialLaura Bonnett, Catrin Tudur Smith, David Smith, et al.
The Cochrane Database of Systematic Reviews|October 23, 2019
Clobazam add-on therapy for drug-resistant epilepsyRebecca Bresnahan, Kirsty J Martin-McGill, John Williamson, et al.
Epilepsia|May 25, 2002
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysisAnthony G Marson, Paula R Williamson, Helen Clough, et al.
The Cochrane Database of Systematic Reviews|February 27, 2014
Topiramate add-on for drug-resistant partial epilepsyJennifer Pulman, Nathalie Jette, Jonathan Dykeman, et al.
BMJ (Clinical Research Ed.)|November 18, 2008
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?David W Chadwick, Gus A Baker, Ann Jacoby, et al.
Epilepsia|November 13, 2010
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic reviewMelissa J Maguire, Karla Hemming, John M Wild, et al.
Epilepsia|November 13, 2010
Factors predictive of resilience and vulnerability in new-onset epilepsyJoanne Taylor, Ann Jacoby, Gus A Baker, et al.
Statistics in Medicine|September 14, 2002
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trialsPaula R Williamson, Helen E Clough, Jane L Hutton, et al.
CNS Oncology|April 17, 2018
The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic reviewKirsty J Martin-McGill, Nisaharan Srikandarajah, Anthony G Marson, et al.
Epilepsia|January 30, 2015
Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trialAnn Jacoby, Maria Sudell, Catrin Tudur Smith, et al.
Pageof 25

Showing results (131-140 of 247) with videos related to

Sort By:
Pageof 25
The Lancet. Neurology|March 2, 2012
Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trialLaura Bonnett, Catrin Tudur Smith, David Smith, et al.
The Cochrane Database of Systematic Reviews|October 23, 2019
Clobazam add-on therapy for drug-resistant epilepsyRebecca Bresnahan, Kirsty J Martin-McGill, John Williamson, et al.
Epilepsia|May 25, 2002
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysisAnthony G Marson, Paula R Williamson, Helen Clough, et al.
The Cochrane Database of Systematic Reviews|February 27, 2014
Topiramate add-on for drug-resistant partial epilepsyJennifer Pulman, Nathalie Jette, Jonathan Dykeman, et al.
BMJ (Clinical Research Ed.)|November 18, 2008
What is the optimal management of partial epilepsy uncontrolled by a first choice anticonvulsant?David W Chadwick, Gus A Baker, Ann Jacoby, et al.
Epilepsia|November 13, 2010
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic reviewMelissa J Maguire, Karla Hemming, John M Wild, et al.
Epilepsia|November 13, 2010
Factors predictive of resilience and vulnerability in new-onset epilepsyJoanne Taylor, Ann Jacoby, Gus A Baker, et al.
Statistics in Medicine|September 14, 2002
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trialsPaula R Williamson, Helen E Clough, Jane L Hutton, et al.
CNS Oncology|April 17, 2018
The role of ketogenic diets in the therapeutic management of adult and paediatric gliomas: a systematic reviewKirsty J Martin-McGill, Nisaharan Srikandarajah, Anthony G Marson, et al.
Epilepsia|January 30, 2015
Quality-of-life outcomes of initiating treatment with standard and newer antiepileptic drugs in adults with new-onset epilepsy: findings from the SANAD trialAnn Jacoby, Maria Sudell, Catrin Tudur Smith, et al.
Pageof 25